.Complying with a poor presenting for Lykos Therapies' MDMA candidate for post-traumatic stress diso...
.AN2 Therapeutics is re-thinking its company in response to poor midphase information, swearing to g...
.Merck & Co. is paying for $700 thousand beforehand to test Amgen in a blood cancer cells market....
.With Gilead Sciences about to an FDA choice for its own liver illness drug seladelpar, the business...
.CEO David Ricks can easily see the business setting up tents at basecamp responsible for Eli Lilly ...
.Cushion Liquidators has actually turned Entero Rehabs white as a sheet. The lender ordered Entero t...
.Exelixis is actually quiting on its tissue element (TF)- targeting antibody-drug conjugate after wr...
.3 weeks after Roche's Genentech device walked away from an SHP2 prevention deal, Relay Rehab has ac...
.Stoke Therapeutics' Dravet disorder drug has been without a partial hold, getting rid of the method...
.Ferocious Biotech Partner Editor Gabrielle Masson provided the 2024 course of Intense 15 winners on...